J Liu, J Santucci, DTS Woon, R Catterwell,
M Perera… - Life, 2024 - mdpi.com
Active surveillance remains a treatment option for low-to intermediate-risk prostate cancer
(PCa) patients. Prostate-specific membrane antigen positron emission tomography and …